Request Deal Involvement

Frazier Life Sciences led a $200m Series A round in AirNexis Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Inizio Evoke Communications

pr advisors

Inizio Evoke Communications

or

Principals

AIRNEXIS THERAPEUTICS

target

AIRNEXIS THERAPEUTICS

FRAZIER LIFE SCIENCES

bidder

FRAZIER LIFE SCIENCES

ORBIMED PE

bidder

ORBIMED PE

SR ONE CAPITAL MANAGEMENT

bidder

SR ONE CAPITAL MANAGEMENT

GOLDMAN SACHS ALTERNATIVES

bidder

GOLDMAN SACHS ALTERNATIVES

LONGITUDE CAPITAL MANAGEMENT CO LLC

bidder

LONGITUDE CAPITAL MANAGEMENT CO LLC

ENAVATE SCIENCES

bidder

ENAVATE SCIENCES

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2026 Datasite

MergerLinks - Request Credit - Frazier Life Sciences led a $200m Series A round in AirNexis Therapeutics.